| Title |
Sarcopenia as a Prognostic Factor among Patients with Stage III Melanoma
|
|---|---|
| Published in |
Annals of Surgical Oncology, August 2011
|
| DOI | 10.1245/s10434-011-1976-9 |
| Pubmed ID | |
| Authors |
Michael S. Sabel, Jay Lee, Shijie Cai, Michael J. Englesbe, Stephen Holcombe, Stewart Wang |
| Abstract |
Several hypotheses proposed to explain the worse prognosis for older melanoma patients include different tumor biology and diminished host response. If the latter were true, then biologic frailty, and not age, should be an independent prognostic factor in melanoma. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 147 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 3 | 2% |
| United States | 1 | <1% |
| Ukraine | 1 | <1% |
| France | 1 | <1% |
| Unknown | 141 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 22 | 15% |
| Student > Ph. D. Student | 20 | 14% |
| Student > Bachelor | 15 | 10% |
| Student > Postgraduate | 14 | 10% |
| Student > Doctoral Student | 13 | 9% |
| Other | 35 | 24% |
| Unknown | 28 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 77 | 52% |
| Agricultural and Biological Sciences | 7 | 5% |
| Nursing and Health Professions | 6 | 4% |
| Engineering | 4 | 3% |
| Neuroscience | 3 | 2% |
| Other | 10 | 7% |
| Unknown | 40 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 April 2023.
All research outputs
#6,666,779
of 23,556,846 outputs
Outputs from Annals of Surgical Oncology
#2,257
of 6,671 outputs
Outputs of similar age
#36,374
of 121,680 outputs
Outputs of similar age from Annals of Surgical Oncology
#9
of 49 outputs
Altmetric has tracked 23,556,846 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 6,671 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 121,680 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.